Skip to content

Clinical observation of rib-oriented percutaneous radiofrequency sympatholysis with different targets in the treatment of primary palmar hyperhidrosis

Clinical observation of rib-oriented percutaneous radiofrequency sympatholysis with different targets in the treatment of primary palmar hyperhidrosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059174
Enrollment
Unknown
Registered
2022-04-26
Start date
2022-04-21
Completion date
Unknown
Last updated
2024-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary palmar hyperhidrosis (PPHH)

Interventions

Group U:The puncture target was the upper margin of the head of the fourth rib
Group L:The puncture target was the lateral margin of the head of the fourth rib

Sponsors

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with severe primary palmhyperhidrosis (HDSS Grade III or IV), including those who have not responded well to conservative management, including topical antiperspirants, traditional Chinese medicine, botox injections, and oral anticholinergics, and who have no history of endoscopic thoracic sympathectomy (VTS).

Exclusion criteria

Exclusion criteria: 1. A history of chronic pain and mental illness. 2. Vascular interventional surgery during preoperative follow-up. 3. Severe liver and kidney insufficiency, poor cardiopulmonary function. 4. Infection of the whole body or chest or back. 5. Abnormal platelet function or coagulation dysfunction caused by long-term oral antiplatelet or anticoagulant drugs. 6. Implant a pacemaker. 7. Incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
the severity of palmhyperhidrosis;Dermatology Life Quality Index (DLQI);perfusion index (PI);palm temperature;

Secondary

MeasureTime frame
height;weight;compensatory hyperhidrosis;adverse reactions;other areas associated with hyperhidrosis;patient satisfaction;

Countries

China

Contacts

Public ContactWu Yue

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

3416236@zju.edu.cn+86 13588846550

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026